DWTX
Dogwood Therapeutics, Inc.Company Information
- Company Name
- Dogwood Therapeutics, Inc.
- CIK
- CIK0001818844
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- DWTX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- DWTX
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-08-21
- Last sale
- 2022-12-08
- Shares purchased (TTM)
- 40,335
- Shares sold (TTM)
- 1,800
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 3,829,726
- Shares outstanding
- 34,129,553
- Ownership
- 11.22%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 6.51%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Redeemable Convertible Preferred Stock | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 10 | 13 | 7 | 10 | 13 | 18 | 15 | 2 | 3 | 2 | 3 | 5 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 1 | 1 | 1 | 0 | ||||||
| Assets Current | 11 | 15 | 8 | 12 | 15 | 19 | 17 | 2 | 4 | 3 | 4 | 5 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Prepaid Expense Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Goodwill | 12 | 12 | 12 | 12 | 12 | 12 | 12 | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 57 | 68 | 69 | 68 | 69 | 66 | 66 | - | - | - | - | - | ||||||
| Deferred Finance Costs Noncurrent Net | - | - | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 80 | 95 | 90 | 92 | 97 | 97 | 94 | 2 | 4 | 3 | 4 | 5 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 1 | 1 | 1 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | 15 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 9 | 12 | 12 | 12 | 12 | 12 | 11 | - | - | - | 0 | - | ||||||
| Liabilities | 12 | 15 | 15 | 15 | 14 | 14 | 30 | 1 | 1 | 1 | 0 | 0 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | 70 | 76 | 76 | 74 | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 196 | 196 | 184 | 73 | 71 | 71 | 68 | 67 | 67 | 66 | 66 | 65 | ||||||
| Retained Earnings Accumulated Deficit | -125 | -113 | -108 | -104 | -89 | -85 | -74 | -66 | -64 | -63 | -61 | -60 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -3 | -2 | -1 | -2 | -0 | -4 | -4 | - | - | - | - | - | ||||||
| Stockholders Equity Before Treasury Stock | 69 | 81 | 75 | 8 | 7 | 7 | -10 | 1 | 3 | 3 | 4 | 5 | ||||||
| Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Stockholders Equity | 68 | 81 | 75 | 7 | 7 | 7 | -10 | 1 | 3 | 3 | 4 | 5 | ||||||
| Preferred Stock Excluding Seriesa And Seriesa1 Non Voting Convertible Preferred Stock | - | - | - | - | 0 | 0 | - | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 80 | 95 | 90 | 92 | 97 | 97 | 94 | 2 | 4 | 3 | 4 | 5 | ||||||
| Seriesa Non Voting Convertible Preferred Stock | 0 | 0 | 0 | -0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Seriesa1 Non Voting Convertible Preferred Stock | 3 | 2 | 2 | 0 | 0 | 0 | 2 | - | - | - | - | - | ||||||
| Seriesa2 Non Voting Convertible Preferred Stock | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Preferred Stock Excluding Seriesa Seriesa1 And Seriesa2 Non Voting Convertible Preferred Stock | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Temporary Equity Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Temporary Equity Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 195 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | ||||||
| Common Stock Shares Issued | 34 | 33 | 30 | 2 | 2 | 2 | 1 | 28 | 1 | 1 | 1 | 1 | ||||||
| Shares Outstanding | 34 | 33 | 30 | 2 | 2 | 2 | 1 | 28 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | - | - | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialDogwood Therapeutics, Inc. (DWTX) — SEC Financial Statements & Analysis
Dogwood Therapeutics, Inc. (DWTX) is a pharmaceutical preparations company, incorporated in DE. Dogwood Therapeutics, Inc. trades on Nasdaq as: DWTX. Dogwood Therapeutics, Inc. (DWTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Dogwood Therapeutics, Inc. carries a market cap of $54.95M, a P/E ratio of -1.58x, a P/B ratio of 0.80x, an enterprise value of $45.34M, and an EV/EBITDA multiple of -1.17x. On profitability, it posts a Return on Equity (ROE) of -92.46%, a Return on Assets (ROA) of -39.26%, and a Return on Invested Capital (ROIC) of -148.40%. Per share, it reports EPS of $-1.02, diluted EPS of $-1.02, free cash flow per share of $-0.44, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 31.21% year-over-year and EPS growth of -92.65% year-over-year. On the balance sheet, it maintains a current ratio of 3.89x, a quick ratio of 3.39x, working capital of $8.19M, a debt-to-equity ratio of 0.18x, a debt ratio of 0.15, an interest coverage ratio of -140.24x, free cash flow of $-15.11M (TTM), and net debt of $-9.61M. Figures sourced from SEC EDGAR.
- Market Cap
- $54.95M
- P/E TTM
- -1.58x
- EPS TTM
- $-1.02
- P/B TTM
- 0.80x
- ROE TTM
- -92.46%
- ROA TTM
- -39.26%
- Debt To Equity
- 0.18x
- Free Cash Flow TTM
- $-15.11M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Dogwood Therapeutics, Inc. in?
Dogwood Therapeutics, Inc. (DWTX) operates in the Pharmaceutical Preparations industry.
What exchange does DWTX trade on?
Dogwood Therapeutics, Inc. (DWTX) trades on the Nasdaq.
Where is Dogwood Therapeutics, Inc. incorporated?
Dogwood Therapeutics, Inc. is incorporated in DE.
When was Dogwood Therapeutics, Inc. (DWTX)'s most recent SEC filing?
Dogwood Therapeutics, Inc. (DWTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is DWTX's market cap?
Dogwood Therapeutics, Inc. (DWTX) has a market capitalization of $54.95M as of 2026-06-30.
What is DWTX's EPS (earnings per share)?
Dogwood Therapeutics, Inc. (DWTX)'s trailing twelve month EPS is $-1.02 as of 2026-06-30.
What is DWTX's ROE (return on equity)?
Dogwood Therapeutics, Inc. (DWTX)'s trailing twelve month Return on Equity (ROE) is -92.46% as of 2026-06-30.
What is DWTX's ROA (return on assets)?
Dogwood Therapeutics, Inc. (DWTX)'s trailing twelve month Return on Assets (ROA) is -39.26% as of 2026-06-30.
What is DWTX's ROIC (return on invested capital)?
Dogwood Therapeutics, Inc. (DWTX)'s trailing twelve month Return on Invested Capital (ROIC) is -148.40% as of 2026-06-30.
What is DWTX's EV/EBITDA?
Dogwood Therapeutics, Inc. (DWTX)'s trailing twelve month EV/EBITDA is -1.17x as of 2026-06-30.